Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA

被引：0
|
作者：
Samant, T. S. [1 ]
Struemper, H. [2 ]
Franzese, R. C. [1 ]
Goulooze, B. [3 ]
Muliaditan, M. [3 ]
Melhem, M. [4 ]
Ghosh, S. [1 ]
Fastenrath, M. [5 ]
Stjepanovic, N. [6 ]
Szijgyarto, Z. [7 ]
Rathi, C. [1 ]
Mantero, A. [1 ]
Hanafin, P. [1 ]
Zajic, S. [1 ]
Yanamandra, N. [1 ]
Chung, C-W.
Vlahovic, G.
机构：
[1] GSK, Collegeville, PA USA
[2] GSK, Durham, NC USA
[3] LAP&P Consultants, Leiden, Netherlands
[4] GSK, Waltham, MA USA
[5] GSK, London, England
[6] GSK, Baar, Switzerland
[7] GSK, Stevenage, Herts, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
基金：
芬兰科学院;
关键词：
mNSCLC; Tumor Size-Overall Survival Modeling; Clinical Pharmacology;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4.11E.28
引用
收藏
页码：S407 / S408
页数：2
相关论文
共 50 条
  • [41] Psoriasis induced by first-line pembrolizumab in metastatic non-small cell lung cancer: A case report
    Gatti, Federica
    Caruso, Gianluca
    Potenza, Concetta
    Santini, Daniele
    Petrozza, Vincenzo
    Annetta, Alessandro
    Ceddia, Serena
    Cosimati, Antonella
    Brandi, Martina
    Sorrentino, Veronica
    Proietti, Ilaria
    Rossi, Luigi
    ONCOLOGY LETTERS, 2023, 26 (01)
  • [42] Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naive Metastatic Non-small Cell Lung Cancer
    Liu, S-Y.
    Zhou, Q.
    Yan, H-H.
    Gan, B.
    Yang, M-Y.
    Deng, J-Y.
    Tu, H-Y.
    Zhang, X-C.
    Su, J.
    Yang, J-J.
    Wu, Y-L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S381 - S382
  • [43] First promising Results of the Combination of Radiation Therapy and Pembrolizumab in Patients with metastatic non-small cell Lung Cancer
    Hecht, Markus
    Gaipl, Udo S.
    Fietkau, Rainer
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 289 - 292
  • [44] Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy
    Paoletti, Martina
    Bini, Chiara
    Marcellusi, Andrea
    Mennini, Francesco Saverio
    CLINICAL DRUG INVESTIGATION, 2024, 44 (08) : 601 - 609
  • [45] Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer
    Thu Oanh Dang
    Ogunniyi, Adebayo
    Barbee, Meagan S.
    Drilon, Alexander
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (01) : 13 - 20
  • [46] Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer
    Gray, Jhanelle E.
    Saltos, Andreas
    Tanvetyanon, Tawee
    Haura, Eric B.
    Creelan, Ben
    Antonia, Scott J.
    Shafique, Michael
    Zheng, Hong
    Dai, Wenjie
    Saller, James J.
    Chen, Zhihua
    Tchekmedyian, Nishan
    Goas, Kristen
    Thapa, Ram
    Boyle, Theresa A.
    Chen, Dung-Tsa
    Beg, Amer A.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6623 - 6632
  • [47] Experience of nivolumab and pembrolizumab in metastatic non-small cell lung cancer in routine clinical practice (mNSCLC.)
    Ksienski, Doran
    Brooks, Edward Geoffrey
    Fenton, Dave
    Fiorino, Leathia
    Geller, Georgia Samantha
    Poonja, Zia
    Glick, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non-Small Cell Lung Cancer
    Qin, A.
    Street, L.
    Viglianti, B. L.
    Cease, K.
    Warren, E. H.
    Ramnath, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 228 - 228
  • [49] Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.
    Goldberg, Sarah B.
    Gettinger, Scott N.
    Mahajan, Amit
    Herbst, Roy S.
    Chiang, Anne C.
    Tsiouris, A. John
    Vortmeyer, Alexander
    Jilaveanu, Lucia
    Speaker, Stephanie
    Madura, Matthew
    Rowen, Elin
    Gerrish, Heather
    Knapp-Perry, Elizabeth
    Yao, Xiaopan
    Chiang, Veronica
    Kluger, Harriet M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer
    Peravali, Monica
    Ahn, Jaeil
    Chen, Kevin
    Rao, Suman
    Veytsman, Irina
    Liu, Stephen V.
    Kim, Chul
    ONCOLOGIST, 2021, 26 (08): : 694 - 700
12345